Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Jerusalem Pharmaceuticals Revenue

Jerusalem Pharmaceuticals had revenue of $11.21M USD in the quarter ending March 31, 2026, with 12.50% growth. This brings the company's revenue in the last twelve months to $50.19M, up 19.82% year-over-year. In the year 2025, Jerusalem Pharmaceuticals had annual revenue of $48.95M with 22.91% growth.

• Revenue (ttm): $50.19M
• Revenue Growth: +19.82%
• P/S Ratio: 2.65
• Revenue / Employee: $84.35K
• Employees: 595
• Market Cap: 94.41M JOD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	48.95M	9.12M	22.91%
Dec 31, 2024	39.82M	168.20K	0.42%
Dec 31, 2023	39.65M	-6.49M	-14.06%
Dec 31, 2022	46.14M	-82.72K	-0.18%
Dec 31, 2021	46.23M	9.83M	27.00%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 7, 2026

Data Sources Report a data error